Current:Home > MarketsNorth Carolina state senator drops effort to restrict access to autopsy reports -DataFinance
North Carolina state senator drops effort to restrict access to autopsy reports
View
Date:2025-04-17 13:16:14
RALEIGH, N.C. (AP) — An effort to exempt autopsy reports from North Carolina’s public records requirements was abandoned Tuesday by a Senate Republican, who said it’s more important to win approval for a streamlined bill that would add punishments for distributing a drug the White House calls an “ emerging threat.”
Spearheaded by Robeson County state Sen. Danny Britt, the new version of the bill removes restrictions that would have shielded autopsy reports from public access until a probe or prosecution is completed. The amended bill then cleared the Senate Judiciary Committee and needs another committee’s approval before it reaches the Senate floor.
The amended bill would add xylazine to a list of drugs that can bring stiff punishments to the distributor when a death results. Xylazine is a sedative not approved for human use, but it’s not federally classified as a controlled substance. The bill also still increases training requirements for county medical examiners and clarifies a medical examiner’s duties when inspecting a body.
“We just wanted to make sure we got that across the finish line and we can maybe come back and look at this other stuff later,” Britt said.
North Carolina currently allows people to inspect and review photos, videos and recordings in autopsy reports under supervision. The bill’s previous iteration would have repealed that law and made the Chief Medical Examiner’s written autopsy reports exempt from public records when they are part of a prosecutor’s criminal investigative file.
When Britt introduced the bill in May, he said public access to autopsy reports is less important than upholding due process for someone being prosecuted, for example by ensuring that jurors aren’t tainted by information from autopsies.
Britt said Tuesday that the only concerns he heard were from the media, not members of the public.
veryGood! (5)
Related
- What to watch: O Jolie night
- 'Modern-day-mafia': 14 charged in Florida retail theft ring that stole $20 million in goods
- Museum plan for Florida nightclub massacre victims dropped as Orlando moves forward with memorial
- Proof That Celebrities Enjoy Dressing Up as Other Stars as Much as We Do
- The Louvre will be renovated and the 'Mona Lisa' will have her own room
- Europe vs. US economies... and a dime heist
- Michigan man starts shaking after winning $313,197 from state lottery game
- Ex-Michigan star says someone 'probably' out to get Wolverines in sign-stealing scandal
- A South Texas lawmaker’s 15
- How a South Dakota priest inspired 125 years of direct democracy — and the fight to preserve it
Ranking
- Highlights from Trump’s interview with Time magazine
- A popular Kobe Bryant mural was ordered to be removed. Here's how the community saved it.
- 2 dead in Mozambique protests over local election results, watchdog says. Police say 70 arrested
- Antarctica is melting and we all need to adapt, a trio of climate analyses show
- Military service academies see drop in reported sexual assaults after alarming surge
- 3 teens were shot and wounded outside a west Baltimore high school as students were arriving
- Alliance of 3 ethnic rebel groups carries out coordinated attacks in northeastern Myanmar
- A spider web of Hamas tunnels in Gaza Strip raises risks for an Israeli ground offensive
Recommendation
NFL Week 15 picks straight up and against spread: Bills, Lions put No. 1 seed hopes on line
Judge in Young Dolph case removes himself based on appeals court order
COVID-19 treatments to enter the market with a hefty price tag
Retired Colombian army officer gets life sentence in 2021 assassination of Haiti’s president
North Carolina justices rule for restaurants in COVID
Mainers See Climate Promise in Ballot Initiative to Create a Statewide Nonprofit Electric Utility
Ex-Michigan star says someone 'probably' out to get Wolverines in sign-stealing scandal
COVID-19 treatments to enter the market with a hefty price tag